Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 22

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 22
---
 Vote Required The affirmative vote of holders representing a simple majority of the total voting rights of shareholders present in person or by proxy who (being entitled to vote) vote on the matter will be required to re-appoint Dr. Herbst to our board of directors as a Class I director. THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RE-APPOINTMENT OF ROY S. HERBST, M.D., PH.D. TO OUR BOARD OF DIRECTORS AS A CLASS I DIRECTOR. 12 TABLE OF CONTENTS RESOLUTION 2 RE-APPOINTMENT OF RANJEEV KRISHANA TO THE BOARD OF DIRECTORS Ranjeev Krishana is currently a member of our board of directors, and has been nominated for re-appointment as a director. If re-appointed, Mr. Krishana will hold office from the date of his re-appointment until the 2028 annual general meeting of shareholders, where he must retire by rotation and offer himself for re-appointment, or until his earlier death, resignation or removal. Mr. Krishana has agreed to serve if re-appointed, and our board of directors has no reason to believe that he will be unable to serve. Ranjeev Krishana has served as a partner at Baker Bros. Advisors LP. (“Baker Bros”) since 2011. Prior to joining Baker Bros., from 2003 to 2007 and from 2008 to 2011, he held a series of commercial, strategy, and business development leadership roles of increasing responsibility at Pfizer, Inc., serving as an executive in their pharmaceutical business across a variety of international regions and markets, including Asia, Europe, and Latin America. Mr. Krishana initially began his career as a strategy consultant at Accenture plc. Mr. Krishana currently serves on the board of directors of BeiGene, Ltd. Mr. Krishana holds a B.A. in Economics and Political Science from Brown University, and a M.P.P. from Harvard University. We believe Mr. Krishana’s extensive scientific background and expertise in cancer treatment and research qualifies him to serve on our board of directors. Vote Required The affirmative vote of holders representing a simple majority of the total voting rights of shareholders present in person or by proxy who (being entitled to vote) vote on the matter will be required to re-appoint Mr. Krishana to our board of directors as a Class I director. THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RE-APPOINTMENT OF RANJ